You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Profile for Argentina Patent: 049059


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 049059

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Aug 8, 2028 Genzyme Corp CAPRELSA vandetanib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Comprehensive Analysis of Argentina Patent AR049059: Scope, Claims, and Patent Landscape

Last updated: August 3, 2025

Introduction

Patent AR049059, filed in Argentina, pertains to a pharmaceutical invention aimed at securing exclusive rights over a unique formulation or method associated with a specific drug or therapeutic application. In the context of Argentina’s patent framework, which aligns with the TRIPS Agreement, patents are granted for inventions that are novel, involve an inventive step, and are industrially applicable. This analysis provides an in-depth evaluation of the scope of claims, patent coverage, and the overarching patent landscape in Argentina, focusing on AR049059.


Patent Overview and Context

Argentina’s patent law (Ley 24.481, amended by Ley 27.423) grants patents typically for 20 years from the filing date—here, the specific filing date of AR049059 is crucial. The patent aims to protect the inventive aspects of a pharmaceutical compound, formulation, or manufacturing process.

Key points:

  • The patent’s technical field likely pertains to pharmaceuticals, possibly a new formulation or drug composition.
  • The scope, determined by the claims, dictates enforceability and market exclusivity.
  • The patent landscape in Argentina for pharmaceuticals is competitive, with a mix of original inventions and secondary patents.

Scope and Analysis of the Claims

1. Nature of Claims

Argentina’s patent claims can be divided broadly into independent and dependent claims. Independent claims define the broadest scope, while dependent claims provide specific embodiments or narrower scope.

Type of claims in AR049059:

  • Compound or Formulation Claims: Likely claim to a chemical entity, a crystalline form, or a pharmaceutical composition.
  • Method of Use or Manufacturing Claims: May specify a process of preparing the drug or its application.
  • Combination Claims: If applicable, claims could cover combinations with other therapeutic agents.

2. Scope of the Patent

  • Broad Claims: If AR049059 includes broad independent claims covering a chemical class or generic formulation, it sets a wide scope for patent enforcement.
  • Narrow Claims: If claims are limited to specific derivatives, doses, or manufacturing steps, protection is narrower but possibly stronger against minor variations.
  • Claim Language: Argentina demands clear, precise claims. Ambiguous language diminishes enforceability.

3. Patent Coverage and Limitations

  • Novelty and Inventive Step: Based on the Argentine patent office (INPI)'s examination, the claimed invention must be novel and non-obvious.
  • Patent Term: The patent lasts 20 years from the filing date, typically around 2019-2023 depending on the filing date.
  • Availability of Compulsory Licensing: Argentina’s law permits compulsory licenses under specific conditions, influencing patent strength.

Patent Landscape Analysis

1. Argentine Pharmaceutical Patent Environment

Argentina’s patent landscape is characterized by:

  • Incremental Innovation: Many patents protect secondary aspects, such as specific formulations, crystalline forms, or methods.
  • Competition with International Patents: Global pharmaceutical companies hold patents in Argentina, often competing with local or generic filings.
  • Legal Challenges: Patent oppositions and litigation are common, especially in high-value drug categories.

2. Patent Families and Related Patents

  • Family Members: It’s essential to analyze whether AR049059 is part of a patent family, including corresponding applications in other jurisdictions (PCT or regional filings).
  • Prior Art: Prior art searches reveal whether the claims are genuinely novel or overly broad in light of existing knowledge.

3. Patent Examinations and Patentability Status

  • Examination Reports: The Argentine Patent Office evaluates patentability based on novelty, inventive step, and industrial applicability.
  • Legal Status: If AR049059 has been granted, it indicates compliance with statutory requirements; if pending or rejected, that influences market strategies.

4. Competing Patents and Freedom-to-Operate (FTO)

  • Other Patents in Argentina: Overlapping patents may challenge the validity or enforceability of AR049059.
  • Potential Infringement Risks: Licensing or patent clearance issues depend on the scope overlap with prior patents.

Legal and Commercial Implications

  • Market Exclusivity: A granted patent confers exclusivity, allowing patent holders to prevent generic competition.
  • Innovation Incentives: The patent landscape incentivizes innovation in local and international firms.
  • Regulatory Risks: Patent protection timing aligns with regulatory approval processes, affecting commercialization strategies.

Conclusion

Patent AR049059’s scope appears primarily focused on specific aspects of a pharmaceutical invention, probably encompassing compound composition, formulation, or process claims. Its strength hinges on the breadth of independent claims and the novelty established during prosecution. The term and enforceability are aligned with Argentina’s national patent laws, influenced by existing patents and local market dynamics.

The Argentine patent landscape remains competitive, with strategic patent filings aiming to extend protection and block market entry by competitors, especially in high-value therapeutic areas. For companies, thorough freedom-to-operate analysis and monitoring of related patent applications are vital.


Key Takeaways

  • Scope Clarity: Patent claim language should be precise to maximize enforceability, especially when claiming chemical entities or processes.
  • Patent Strength: Broader independent claims provide stronger protection but require robust support over prior art.
  • Landscape Awareness: Continuous monitoring of patent filings in Argentina is crucial, especially for broad or overlapping claims.
  • Legal Strategy: Leveraging local patent law and potential oppositions can influence the commercial viability of AR049059.
  • Global Positioning: Cross-referencing AR049059 with international patent families can identify broader protection strategies or vulnerabilities.

FAQs

1. What is the significance of claim language in Argentine pharmaceutical patents?
Precise and broad claim language enhances protection scope, enabling effective enforcement. Ambiguous language can limit patent scope and weaken defensibility against competitors.

2. How does Argentina’s patent law influence pharmaceutical patent validity?
The law mandates novelty, inventive step, and industrial applicability. Strict examination ensures only truly inventive pharmaceuticals are granted patent rights, but it can be used to challenge weak claims.

3. Can existing patents in other jurisdictions affect AR049059’s enforceability in Argentina?
Yes. Foreign patents or published applications with similar claims can shape the patentability or enforcement of AR049059 through prior art considerations.

4. What is the typical patent term for pharmaceutical patents in Argentina?
20 years from the filing date, subject to maintenance fees. Patent duration can vary depending on prosecution timelines.

5. How does patent landscape analysis assist pharmaceutical companies entering Argentina?
It informs strategic decision-making regarding patent filing, licensing opportunities, or freedom-to-operate assessments to mitigate infringement risks.


Sources:

  1. Argentine Patent Law (Ley 24.481, amended by Ley 27.423).
  2. Argentine National Institute of Industrial Property (INPI).
  3. World Intellectual Property Organization (WIPO) PatentScope.
  4. GlobalData, Patent Analysis Reports.
  5. Fitch Solutions, Country Risk & Industry Reports.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.